Table 3:
Female | Male | Both | |
---|---|---|---|
ApoE genotype | |||
ε3/ε3 | Reference Group* | Reference Group* | Reference Group* |
ε2/ε3 | P=0.522 OR=0.663 (0.22–1.75) | P=0.104 OR=0.23 (0.05–1.13) | P=0.086 OR=0.44 (0.19–1.03) |
ε3/ε4 | P=0.001 OR=7.86 (2.58–23.9) | P=0.080 OR=4.7 (0.96–22.8) | P=0.001 OR=6.52 (2.63–16.17) |
ε4/ε4 | No data | P=0.319 OR=7.3 (0.37–144.8) | P=0.236 OR=8.55 (0.44–167. 3) |
ε3/ε4+ ε4/ ε4 | P=0.001 OR=7.86 (2.58–23.9) | P=0.022 OR=6.25 (1.33–29.4) | P=0.001 OR=7.1 (2.9–17.6) |
APOE allele | |||
ε3 | Reference Group* | Reference Group* | Reference Group* |
ε4 | P=0.001 OR=5.59 (2.07–15.05) | P=0.002 OR=8.3 (1.86–37) | P=0.001 OR=6.3 (62.8-14.45) |
ε2 | P=0.157 OR=0.46 (0.17–1.19) | P=0.878 OR=0.8 (0.29–2.24) | P=0.185 OR=0.59 (0.29–1.18) |
This group assumed as reference group for comparison.